Researchers Showcase How AACR Project GENIE is Powering New Insights into Cancer Care
Previous
Previous
GUARDIAN-101: A first in human, tumor agnostic phase 1 study evaluating safety and preliminary antitumor activity of CLSP-1025.
Next
Next